ACCELERATING PRECISION MEDICINE
Population Bio’s mission is to make drugs safer and more effective. We accelerate the delivery of precision medicine products to patients by discovering disease-relevant genetic biomarkers that enable:
- Companion diagnostic test development to identify patients at risk of a serious adverse event (SAE) for currently marketed drugs.
- Drug repurposing (repositioning) for new indications based on genetic subtypes of common diseases.
- Drug rescue of promising therapies that fail in clinical trials for safety or efficacy.
- Disease-modifying drug development for novel targets based on genetic discoveries (causal or protective variants).
Population Bio’s CNV Beacon® platform reduces the genome search space for faster, lower cost discovery of disease-relevant genes and variants.